Cell-Surface Proteomics Identifies Lineage-Specific Markers of Embryo-Derived Stem Cells  by Rugg-Gunn, Peter J. et al.
Developmental Cell
ResourceCell-Surface Proteomics Identifies
Lineage-Specific Markers
of Embryo-Derived Stem Cells
Peter J. Rugg-Gunn,1,8,9 Brian J. Cox,1,8,10 Fredrik Lanner,1,8 Parveen Sharma,2 Vladimir Ignatchenko,4
Angela C.H. McDonald,1,5 Jodi Garner,1 Anthony O. Gramolini,2,6 Janet Rossant,1,3,* and Thomas Kislinger4,7,*
1Program in Developmental and Stem Cell Biology, Hospital for Sick Children Research Institute, 555 University Avenue, Toronto,
ON M5G 1X8, Canada
2Department of Physiology
3Department of Molecular Genetics
University of Toronto, 1 King’s College Circle, Toronto, ON M5S 1A8, Canada
4Ontario Cancer Institute, University Health Network, The Campbell Family Cancer Research Institute, 610 University Avenue, Toronto,
ON M5G 2M9, Canada
5Institute of Biomaterials and Biomedical Engineering, University of Toronto, 164 College Street, Toronto, ON M5S 3G9, Canada
6Division of Cellular and Molecular Biology, Toronto General Research Institute
7Department of Medical Biophysics
University of Toronto, 610 University Avenue, Toronto, ON M5G 2M9, Canada
8These authors contributed equally to this work
9Present address: The Babraham Institute, Cambridge CB22 3AT, UK
10Present address: Department of Physiology, University of Toronto, 1 King’s College Circle, Toronto, ON M5S 1A8, Canada
*Correspondence: janet.rossant@sickkids.ca (J.R.), thomas.kislinger@utoronto.ca (T.K.)
DOI 10.1016/j.devcel.2012.01.005Open access under CC BY license.SUMMARY
The advent of reprogramming and its impact on stem
cell biology has renewed interest in lineage restric-
tion inmammalian embryos, the source of embryonic
(ES), epiblast (EpiSC), trophoblast (TS), and extraem-
bryonic endoderm (XEN) stem cell lineages. Isolation
of specific cell types during stem cell differentiation
and reprogramming, and also directly from embryos,
is a major technical challenge because few cell-
surface proteins are known that can distinguish
each cell type. We provide a large-scale proteomic
resource of cell-surface proteins for the four
embryo-derived stem cell lines. We validated 27 anti-
bodies against lineage-specific cell-surfacemarkers,
which enabled investigation of specific cell popula-
tions during ES-EpiSC reprogramming and ES-to-
XEN differentiation. Identified markers also allowed
prospective isolation and characterization of viable
lineage progenitors from blastocysts by flow cytom-
etry. These results provide a comprehensive stem
cell proteomic resource and enable new approaches
to interrogate the mechanisms that regulate cell fate
specification.
INTRODUCTION
Stem cells derived from early embryos or reprogrammed from
somatic cells can be used for the study and treatment of degen-
erative diseases and hold tremendous promise for the future of
regenerative medicine (Murry and Keller, 2008; Yamanaka,Deve2007). The potential to generate an array of differentiated cell
types also raises the opportunity to establish new models of
early mammalian development (Rossant, 2008). However, a
lack of validated cell-surface markers for flow cytometric anal-
ysis and isolation have created road blocks in these fields
(Dubois et al., 2011; Van Hoof et al., 2010). For example, major
challenges currently faced within regenerative medicine include
the assessment of purity of stem cells or stem cell-derived pop-
ulations, the former to confirm faithful cellular reprogramming
and the latter to eliminate the risk posed by introduction of undif-
ferentiated stem cells in vivo. To address this shortcoming, we
have examined the cell-surface proteome of the four stem cell
lines that are derived from early mouse embryos and applied
newly identified protein markers to study differentiation and
reprogramming.
The epiblast progenitors (EPIs) of preimplantation blastocysts
comprises the pluripotent cells that give rise to all germ layers of
the later fetus and are also the tissue source from which embry-
onic stem (ES) cells are derived (Brook andGardner, 1997; Evans
and Kaufman, 1981; Martin, 1981; Nichols and Smith, 2011).
Epiblast stem cells (EpiSCs) are isolated from EPI of early post-
implantation embryos and are maintained in a pluripotent state
that is distinct from ES cells (Brons et al., 2007; Tesar et al.,
2007). The two extraembryonic lineages of the blastocyst also
give rise to stable stem cell lines. The outer trophectoderm (TE)
layer generates the trophoblast of the placenta and trophoblast
stem (TS) cells, and the primitive endoderm (PE) contributes to
extraembryonic yolk sac endoderm and gives rise to extraem-
bryonic endoderm stem (XEN) cells (Kunath et al., 2005; Tanaka
et al., 1998). Importantly, each stem cell type retains the defining
properties and lineage restriction of their in vivo tissue of origin,
and therefore provide a useful system in which to study stem cell
biology and early mammalian development.lopmental Cell 22, 887–901, April 17, 2012 ª2012 Elsevier Inc. 887
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Cell-Surface Stem Cell ProteomicsFew cell-surface proteins are known that can distinguish each
stem cell type and their in vivo sources within the embryo. Micro-
array gene expression data from early embryos have beenmined
successfully to identify two PE-specific cell-surface proteins
(Gerbe et al., 2008; Plusa et al., 2008). However, the presence
of RNA does not always correlate with the presence of the
protein (Cox et al., 2009). Furthermore, a recent study revealed
that of all protein classes examined, cell-surface proteins in
particular show poor correlation between protein and RNA abun-
dance when comparing cell types (Lundberg et al., 2010). These
studies suggest that RNA expression may be an unreliable
predictor of cell-specific cell-surface protein expression and
that direct proteomic approaches are required to identify protein
markers that can distinguish cell types of the early embryo. A
large-scale analysis of lineage-specific cell-surface protein
expression would also identify those proteins actually involved
in important cell signaling, cell adhesion and cell migratory
processes during early development and stem cell formation.
We have developed a direct proteomic approach to explore
the cell-surface proteome for all four embryo-derived stem cell
lines using affinity labeling and mass spectrometry. Antibodies
against lineage-specific cell-surface proteins enabled identifica-
tion and isolation of specific cell populations during stem cell
differentiation and reprogramming. Our analysis identified mole-
cules with potential importance in separation and migration of
EPI and PE, and of differences in cell signaling between ES cells
and EpiSC. Furthermore, cell-surface protein markers allowed
prospective isolation and characterization of viable EPI, PE,
and TE directly from mouse blastocysts. These results provide
a comprehensive stem cell proteomic resource and enable
new approaches to interrogate the mechanisms that regulate
cell fate specification.
RESULTS
Cell-Surface Proteome of Embryo-Derived Stem Cell
Lineages
ES, TS, XEN, and EpiSC were biotinylated with the membrane-
impermeable reagent sulfo-NHS-SS-biotin (Figure 1A), which
binds to primary amines of cell-surface proteins (Roesli et al.,
2006). Individual lysates from biotinylated ES, TS, XEN, and
EpiSC were prepared, and biotinylated proteins were affinity
captured to collect cell-membrane-enriched protein samples.
For comparison, proteins that did not bind to the beads were
also collected. These should be depleted in cell-surface proteins
but contain cytoplasmic and nuclear proteins (membrane-
depleted whole cell samples). Samples were analyzed by mass
spectrometry in quadruplicate using a MudPIT approach (Taylor
et al., 2009). A total of 3,432 proteins were identified (1,758 for
ES; 2,391 for TS; 2,442 for XEN; 2,169 for EpiSC; see Table S1
available online), which represents one of the largest mouse
stem cell protein data sets reported (Van Hoof et al., 2006;
Wang et al., 2008a).
Gene Ontology (GO) analysis revealed that biotinylated frac-
tions were highly enriched for plasma membrane proteins and
depleted in nonplasma membrane proteins (p < 1 3 1013,
Fisher’s exact test). This suggests that cell-surface proteins
had been successfully captured. However, one caveat of chem-
ical labeling strategies and organellar purifications in general is888 Developmental Cell 22, 887–901, April 17, 2012 ª2012 Elsevier Ithe detection of proteins with annotations other than the organ-
elle of interest (Bergeron et al., 2010), which could hinder the
identification of lineage-specific cell surface proteins. To
address this challenge, we developed a data mining strategy
to predict proteins that are localized to the cell surface.
Machine-learning algorithms (Hall et al., 2009b) and training
sets of known membrane-localized and non-membrane-
localized proteins were used to build a model that categorized
each protein as belonging to the cell surface or not (Figure 1B).
Applying this stringent model to our data identified 551 proteins
predicted to be localized at the cell surface (220 for ES; 222 for
TS; 212 for XEN; 416 for EpiSC; Table S2).
As expected, these data revealed a strong enrichment for
functional classes that are characteristic of cell-surface proteins,
including signaling receptors, cell adhesion and cell migration
molecules (Figure 1C and Table S3). The data set contains
shared and cell-type-specific proteins within many functional
classes, thereby revealing important differences in their protein
profiles (Tables 1 and 2). For example, signaling receptors known
to be involved in regulating stem cell self-renewal were detected,
including Lifr in ES cells, Fgfr2 in TS cells, and Fgfr1 in EpiSC. In
addition, Notch receptors were identified in EpiSC, but not in ES
cells, suggesting differences may exist between pluripotent cell
types. Interestingly, we identified numerous Ephrin and Slit
receptors in ES and XEN cells. Their known roles in cell guidance
andmigration could provide amechanism to explain the process
of cell sorting that occurs during EPI and PE segregation (Brose
and Tessier-Lavigne, 2000; Genander and Frise´n, 2010; Plusa
et al., 2008). Thus, our proteomic data set will provide an impor-
tant resource of cell-surface proteins that are present on stem
cells and could be used in future functional studies to interrogate
the mechanisms of self-renewal and differentiation.
Protein Abundance Is a Reliable Predictor of Cell-Type
Specificity
Although previous studies have shown that RNA expression
alone can be used to predict cell-specific protein expression
(Gerbe et al., 2008; Plusa et al., 2008), the presence of RNA
does not always correlate with the presence of the protein
(Cox et al., 2009; de Sousa Abreu et al., 2009; Lundberg et al.,
2010) suggesting that RNA expressionmay be an unreliable indi-
cator of cell-specific protein expression. To determine whether
the set of cell-specific membrane proteins identified in this
current study could have been predicted by RNA expression
alone, we integrated genome-wide transcriptional profiles into
the protein data set (Table S4). Pairwise comparison of the differ-
ence in RNA and protein expression between cell types revealed
a subset of cell-surface proteins that would have been identified
as cell-specific using transcriptional profiling alone (Figure 1D).
However, a larger set of cell-surface proteins showed poor
correlation between RNA and protein abundance when com-
paring cell types and would not be predicted to be cell-specific
using transcriptional information alone (Figure 1D). For this set
of proteins, RNA transcripts were detected at equivalent
(<2-fold difference) levels between cell types, despite robust
differences in protein abundance. The cell-specific protein ex-
pression of ten proteins within this set was confirmed using
antibodies (see below). Disagreement between transcript and
protein abundance was prevalent when comparing two cell lines.nc.
Figure 1. Mapping the Cell-Surface Proteome of Mouse Embryo-Derived Stem Cells
(A) Experimental design used to identify cell-surface proteins. Immunofluorescent microscopy reveals that the biotin label is located at the cell surface in all four
stem cell lines. See Table S1 for complete protein data set.
(B) Scatter plots showmean folddifference inprotein abundancebasedonspectral counting (log2 transformed) between themembrane-enriched fractionandwhole-
cell fraction on the y axis, and themeanprotein abundance (log2 transformed) fromboth fractionson the x axis. Theproteinsdisplayed are thosewithGOannotations
for cellular location and therefore not all proteins are shown. Dashed lines indicate ratios used to categorize proteins as belonging to the cell surface or not.
(C) Functional classification of identified proteins reveals enrichment for biological processes associatedwith the cell surface. Fold enrichment is relative to whole
genome annotations and are highly significant (p < 0.005, Fisher’s exact test). See Table S3 for gene ontology data.
(D) Scatter plots show difference in protein abundance based on spectral counting (log2 transformed; y axis) and RNA expression (log2 transformed; x axis)
between cell lines for all proteins detected. See Table S4 for individual values. Left panel compares ES and TS cells; middle panel compares ES and XEN cells;
right panel compares ES and EpiSC. Cell-surface proteins validated by antibody staining are highlighted. Dashed lines indicate 2-fold change in RNA expression
between cell lines.
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Cell-Surface Stem Cell ProteomicsFor instance, discordance between RNA and protein for ES and
TS cells occurred for 89/143 (62%) cell-surface proteins. Poor
concordance also impacts the reliable identification of cell-
specific membrane proteins. Thus, overall only 21 of 178 (12%)
cell-specific membrane proteins would have been identified by
analysis of RNA expression alone (Table S4). As an example,
levels of Pecam1 transcript, a strong marker of ES cells (Robson
et al., 2001; Vittet et al., 1996), were similar in ES and TS cells
(confirmed by quantitative RT-PCR; data not shown), but
Pecam1 protein was detected only in ES cells (34 spectral
counts in ES cells, 0 in TS cells; Table S4; confirmed by antibody
in Figure 2). Poor concordance between protein and transcript
expression for cell-surface proteins are consistent with previous
studies and, together with our data, suggest that protein is
a more reliable predictor of cell-type specificity than RNA
expression alone. These data reinforce the need for a direct pro-
teomic approach for protein marker discovery.DeveCell-Surface Protein Markers Enable Isolation of
Lineage-Specific Stem Cells
Many cell-surfaceproteins identifiedwereunique tooneor another
cell line and provide an important set of lineage-specific markers
(Table S2). Comparison between ES, TS and XEN cells revealed
71 cell-surface proteins unique to ES cells, 74 to TS cells and 66
to XEN cells (Figure 2A). Comparison between ES cells and
EpiSC revealed 60 cell-surface proteins unique to ES cells and
256 to EpiSC (Figure 3A). We sought to use these protein
markers to define a cell-surface protein signature for each cell
type that would enable unambiguous detection of specific cells
during stem cell differentiation and reprogramming. As an initial
step, we screened a panel of commercially available antibodies
for those that were able to detect the lineage-specific proteins
identified. Of 52 membrane proteins examined, 27 revealed the
expected cell-specific cell-surface expression pattern (Figures
2B and 3B; Figure S1) and 25 antibodies failed due to absencelopmental Cell 22, 887–901, April 17, 2012 ª2012 Elsevier Inc. 889
Table 1. Functional Classification of the Plasma Membrane Proteins Identified in ES, TS, and XEN Cells
Unique ES Unique TS Unique XEN Multiple Cell Types
Signal Transduction
Integrin Itga9 Itga7; Itgb3; Itgb5  Itga3; Itga5; Itga6; Itgav;
Itgb1; Ptk2; RhoA
FGF Fgfr1 Fgfr2 Hhip 
Wnt Wntlrp1   Ctnnb1; Slc9a3r1
BMP Gpc3 Htra1  
TGF-b  Htra1  Spnb2
Hedgehog   Hhip Ctnna1
Notch  Notch3 Adam10; Notch2 Ncstn
Insulin  Sorbs1  Insr
Phosphatase    Ptprb; Ptprf; Ptprg; Ptprk
G-protein Lgr4; Lphn1; V1rc6 Gnaq Ric8 Cd97; Gna11; Gna13; Gnai3;
Gnas; Gnb2l1; Gnb1; Lphn2;
Olfr54; Tacr1
Small GTPase Pecam1 Rab13 Rheb; Sar1b Arf1; Arf4; Arf5; Arf6;
Arhgap1; Arhgdia; Gna13;
Gnb1; Grb2; Rab5a; RhoA;
RhoC; Rras2
Second messenger Ncam1 Gnaq; L1cam  Gna11; Gnas; Gnb1; Gnb2l1;
Slc9a3r1
Cell-Cell Adhesion
Enah; Pvrl2; Pvrl3 Arvcf; Cldn3; Dsc2;
L1cam; Pkp2
Cdh6; Pdpn Cadm1; Cdh3; Cdh5;
Ctnnb1; Dsg2; Fat1; Icam1;
Itga5; Itga6; Lgals1; Mcam;
Myh9; Nrcam; Pcdh1; Pnn;
Ptk7; Tek; Vasp
Cell Migration
Alcam; Enah; Epha4;
Ephb2; Mmp14; Pecam1
Itgb3; L1cam; Scarb1;
Shroom2
B4galt1; Gja1; Pdpn;
Robo2
Col18a1; Enpep; Ephb3;
Gab1; Gna13; Itga3; Itga6;
Lama1; Lama5; Myh10;
Nrcam; Pafah1b1; Podxl;
Ptk2; Robo1; Rras2; St14;
Tek; Vasp; Vcl
The plasma membrane proteins were grouped into signal transduction pathways, cell-cell adhesion, and cell migration functions according to their
GO annotation. Given are the gene symbols of the proteins identified. Proteins shown were detected uniquely in one cell type or common to more
than one cell type.
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Cell-Surface Stem Cell Proteomicsof signal in all assays tested or were detected as multiple bands
by western blot (see Supplemental Experimental Procedures for
antibody details). Of the 27 confirmed proteins, two have been
identified previously: Pecam1 in EPI/ES cells and Pdgfra in
PE/XEN cells, and provide further validation of our data (Plusa
et al., 2008; Robson et al., 2001; Vittet et al., 1996). To the best
of our knowledge, the remaining 25 confirmed cell-surface pro-
teins have not been described previously for ES, TS, XEN, or
EpiSC, thereby revealing stem cell-specific expression patterns.
We tested whether the cell-surface proteins, and the anti-
bodies that bind to them, could be used for flow cytometry.
Nine antibodies gave strong and cell-specific signals: Pecam1,
Cd81 antigen, and Pvrl3 for ES cells; Cdcp1 and Cd40 antigen
for TS cells; Pdgfra, Dpp4, and Robo2 for XEN cells; Cd40
antigen and Cd47 antigen for EpiSC (Figures 2C, 3C, and 3D).
Importantly, combinations of these antibodies could separate
a mixed population of ES, TS, and XEN cells into individual cell
types by flow cytometry (Figure 2D). These results were890 Developmental Cell 22, 887–901, April 17, 2012 ª2012 Elsevier Iconfirmed using additional ES, TS, and XEN cell lines (data not
shown), demonstrating the robustness of these markers. We
have, therefore, greatly expanded our knowledge of stem cell
specific cell-surface proteins and have identified combinations
of antibodies that are able to separate a mixed population of
cell types into their individual lineages.
Analysis of Cellular Reprogramming, ES Cells to XEN
Cells
Monitoring the depletion of progenitor cells and the appearance
of a new population is critical to optimization of differentiation
and reprogramming protocols. To examine this further, we
used our cell-specific protein markers to track changes in cell
fate during conversion of ES cells into XEN cells. To achieve
this, the PE transcription factor Sox17 was overexpressed in
ES, which has been shown previously to promote ES cell
to XEN cell conversion (Niakan et al., 2010; Qu et al., 2008;
Shimoda et al., 2007). We used a doxycycline-inducible systemnc.
Table 2. Functional Classification of the Plasma Membrane Proteins Identified in ES Cells and EpiSC
Unique ES Unique EpiSC ES and EpiSC
Signal Transduction
Integrin Itga9; RhoA Adam17; Cd47; Itga1; Itgb4;
Itgb5; Ptk2
Itga3; Itga5; Itga6; Itgav; Itgb1
FGF   Fgfr1
Wnt  Ror2 Ctnnb1; Lrp1a; Slc9a3r1
BMP   Gpc3
TGF-b   Spnb2
Hedgehog   Ctnna1
Notch  Adam17; Notch1; Notch2;
Notch3
Ncstn; Nle1
Insulin Insr  
Phosphatase Ptprb Ptprd; Ptprf; Ptprg; Ptprk
G-protein Lphn1; V1rc6 Gna11; Gna13 Cd97; Gnai3; Gnas; Gnb1; Gnb2l1; Lgr4;
Lphn2; Tacr1
Small GTPase Arf6; Pecam1; RhoA B230208h17rik; Gna13; Itsn1;
Rab12
Arf1; Arf4; Arf5; Arhgap1; Arhgdia; Gnb1;
Rab5a; Rab6; Rap1a; RhoC
Second messenger  Gna11; L1cam Gnas; Gnb1; Gnb2l1; Ncam1; Slc9a3r1
Cell-Cell Adhesion
Pvrl3; Tek Cdh2; Cdh4; Cdh10; Dsc2;
Frem2; L1cam; Pcdh7; Pdpn;
Ror2; Shroom3; Vasp
Cadm1; Cdh3; Ctnnb1; Dsg2; Enah; Fat1;
Icam1; Itga5; Itga6; Lgals1a; Mcam; Myh9;
Nrcam; Pcdh1; Pnn; Ptk7; Pvrl2
Cell Migration
Enpep; Epha4; Ephb2; Gab1;
Mmp14; Pecam1; Tek
Cdh2; Cdh4; Erbb2; Gna13;
Itga1; Kif5c; L1cam; Nfasc;
Pdpn; Ptk2; Shroom2; Vasp
Alcam; Col18a1; Enah; Ephb3; Itga3;
Itga6; Lama1b; Lama5; Nrcam; Pafah1b1;
Podxl; Robo1; Scye1; St14; Vcl
The plasmamembrane proteins were grouped into signal transduction pathways, cell-cell adhesion, and cell migration functions, according to their GO
annotation. Given are the gene symbols of the proteins identified. Proteins shown were detected uniquely in one cell type or common tomore than one
cell type.
aEpiSC > ES by 20-fold.
bES > EpiSC by 20-fold.
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Cell-Surface Stem Cell Proteomicsin order to study early changes in cell state upon Sox17 expres-
sion. Using a panel of six antibodies (Pecam1, Cd81, and Pvrl3
for ES cells; Dpp4, Pdgfra, and Robo2 for XEN cells) we
observed by flow cytometry a complete conversion in cell
phenotype within 8–12 days of Sox17 induction (Figure 2E; Fig-
ure S2). The converted cells were indistinguishable by flow
cytometry from embryo-derived XEN cells and their change in
cell fate was confirmed using gene expression analysis (Fig-
ure 2E; Figure S2). Interestingly, on day four, approximately
one-third of the cells undergoing conversion were negative for
both ES cell and XEN cell markers, indicating that an initial
step in the differentiation process is the downregulation of ES
cell proteins and this event precedes upregulation of XEN cell
proteins. By day eight, the majority (>90%) of cells were positive
for XEN cell markers with a minor proportion of negative cells.
Together, these data confirm the fidelity of identified cell-specific
cell-surface proteins and reveal the temporal and sequential
changes in cell state that occur upon transcription factor medi-
ated lineage conversion.
Cell-Surface Proteins Distinguish ES Cells and EpiSC
during Differentiation and Reprogramming
ES cells and EpiSC are pluripotent stem cells that recapitulate
the pre- and postimplantation EPI of early mouse embryos,Deverespectively. The two stem cell types differ in terms of gene
expression profiles, growth factor requirements, epigenetic
status and developmental potency (Rossant, 2008). Better
understanding of ES cells and EpiSC is important for identifying
how pluripotency is regulated and may also provide clues to
explain the differences between human and mouse ES cells,
with the former being more akin to EpiSC. Mouse ES cells and
EpiSC can be interconverted by alteration of culture conditions
augmented by forced expression of key transcription factors
such as Nanog and Klf4 (Bao et al., 2009; Greber et al., 2010;
Guo and Smith, 2010; Guo et al., 2009; Hall et al., 2009a; Hanna
et al., 2010; Silva et al., 2009; Theunissen et al., 2011). However,
no cell-surface markers have been shown to functionally isolate
the two stem cell types from each other and instead previous
reports have relied on transgene expression or cell morphology.
Applying our proteomic data set to this deficit, we sought to
identify cell-surface proteins that could distinguish between ES
cells and EpiSC as this would allow unambiguous identification
and quantification during the process of cell conversion.
Our proteomic analysis and subsequent validation by anti-
bodies identified nine cell-specific membrane proteins that are
expressed by either ES cells or EpiSC: Pecam1, Pvrl3, and
Cd81 antigen for ES cells; Notch3, Cd40 antigen, Cdh10, Sirpa,
Cd47 antigen, and Cdh2 for EpiSC (Figures 3A and 3B).lopmental Cell 22, 887–901, April 17, 2012 ª2012 Elsevier Inc. 891
Figure 2. Identified Cell-Surface Proteins Can Be Used to Investigate Cell Fate Changes during Differentiation
(A) Venn diagram showing overlap of all cell-surface proteins detected in ES, TS, and XEN cells. See Table S2 for a list of proteins within each category.
(B) Immunofluorescent microscopy reveals the cellular localization and cell line specificity of candidate cell-surface proteins. Scale bar, 50 mm.
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Cell-Surface Stem Cell ProteomicsWe applied established cell culture conditions to drive the
conversion of ES cells into EpiSC (Guo et al., 2009; Zhang
et al., 2010). Changes in cell fate during this process were moni-
tored by flow cytometric analysis of Pecam1, Cd81, and Cd40.
The flow analysis revealed a progressive change in cell pheno-
type, whereby75%of cells had downregulated ES cell markers
by day two (Figure 3C). By day five, cells were indistinguishable
from embryo-derived EpiSC by flow cytometry (Figure 3C). The
cells could be maintained in EpiSC culture conditions and
revealed a gene expression profile highly similar to EpiSC (Fig-
ure 3C), thereby confirming successful cell conversion. These
experiments also provided important validation of the identified
proteinmarkers and their suitability for analyzing ES cell to EpiSC
differentiation.
EpiSC to ES cell reprogramming is an inefficient process (1%
in published studies) (Guo et al., 2009) and is therefore depen-
dent on the accurate detection and isolation of reprogrammed
cells. We transferred Nanog-expressing EpiSC into stringent
ES cell conditions (termed 2i/LIF) and used flow cytometry to
detect the appearance of reprogrammed ES cells. We found
that an antibody combination of Pecam1 together with Cd47 or
Cd40 provided the most robust readout. Reprogrammed cells
(defined here as Pecam1 positive and Cd47 negative) were de-
tected on day nine and this population increased to 1%–5%
on day 13 (Figure 3D). Each cell population was isolated by
flow cytometry and their gene expression profile was analyzed
using qRT-PCR. Reprogrammed cells showed expression of
ES cell factors Esrrb, Klf2, and Fbox15 at similar levels to
embryo-derived ES cells and had downregulated EpiSC factors
Fgf5, Cer1, and T, suggesting successful reversion (Figure 3E).
To test this further, we used flow cytometry to purify reprog-
rammed cells and transferred the cells into 2i/LIF conditions.
The reprogrammed cells formed compact ES cell-like colonies,
which were positive for alkaline phosphatase activity and ex-
pressed the ES cell factor Klf4, thereby confirming their cellular
identity (Figure 3F). In contrast, EpiSC that failed to reprogram
(defined here as Pecam1 negative and Cd47 positive) did not up-
regulate ES cell gene expression profiles or form alkaline phos-
phatase positive colonies in 2i/LIF (Figures 3E and 3F). Instead,
these cells showed upregulation of neural markers Nestin and
Pax6 (Figure 3E), which is consistent with a previous study that
showed neural induction after EpiSC treatment with FGF inhibi-
tors (Greber et al., 2010). Lastly, we examined whether the cells
had undergone epigenetic reprogramming by examining the
methylation status of the Dppa3 (also known as Stella) promoter
region, which is highly methylated in EpiSC and unmethylated in
ES cells (Hayashi et al., 2008). Bisulphite sequencing revealed(C) Flow cytometry histograms showing fluorescence intensity of eight cell-surface
are presented as percentage maximum counts for each sample; 10,000 final cou
(D) Representative flow cytometry dot plot showing Pecam1, Cd40 and Pdgfra ex
Cells were sorted by flow cytometry using a combination of antibodies against
Sorted cells were analyzed by qRT-PCR for gene expression levels of known line
high levels of ES-specific genes Pou5f1 (also known as Oct4) and Nanog; Cdcp1-
Eomes; Pdgfra and Dpp4-positive cells expressed high levels of XEN-specific g
with highest expression. Error bars, SD (n = 3 biological replicates). See Figure S
analysis.
(E) ES cell to XEN cell conversion was induced by forcing Sox17 expression in ES
monitored by flow cytometry every four days. Additional cell-surface markers, i
Figure S2.
Devethat reprogrammed cells isolated by flow cytometry on day 12
had an unmethylated Dppa3 promoter, whereas EpiSC that
failed to reprogram remained fully methylated (Figure 3F). The re-
programmed cells, therefore, share molecular features with ES
cells and not with EpiSC. Taken together, these studies have
identified a panel of cell-surface protein markers that are able
to distinguish ES cells and EpiSC during differentiation and re-
programming. These results now enable the accurate detection
and isolation of specific cell populations without the need to use
transgenic reporter cell lines.
Identified Cell-Surface Proteins Are Expressed in
Lineage-Appropriate Manner In Vivo
Better understanding of the molecular determinants of cell fate
decisions and the precise timing of lineage restriction during
early embryo development is essential for effective use of stem
cells. Progress toward understanding these issues is contingent
on the ability to prospectively isolate and characterize each cell
lineage directly from blastocysts; however this remains a major
technical challenge. Our panel of validated ES, TS, and XEN
cell-surface proteins and antibodies present an opportunity to
establish conditions that could enable these new approaches.
We investigated whether the identified cell-surface proteins
were expressed by their in vivo tissue of origin. Embryos were
examined by immunofluorescence and costained with known
lineage markers Nanog, Oct4, Cdx2, and Gata6 to verify the
identity of each cell type (Figure 4A). In embryonic day E4.5 blas-
tocysts, ES cell markers Pecam1, Cd81, Plxna4, and Pvrl3 local-
ized to the cell surface of EPI with no signal detected in PE or TE
(Figure 4A). XEN cell proteins Pdgfra and Dpp4were restricted to
PE with no expression detected in EPI or TE, and TS cell proteins
Cdcp1, Ggt1, and Scarb1 localized specifically to TE (Figure 4A).
Curiously, Robo2 and Cd40 were not detected at this stage of
development (Figure 4A). We therefore examined E5.5 embryos
and found that the XEN cell protein Robo2 was expressed by
parietal endoderm cells, which are a specific cell type derived
from PE (Figure 4B). In addition, the TS cell protein Cd40 was
detected throughout the trophoblast of E5.5 embryos, thereby
revealing a strong stage-specific expression pattern (Figure 4B).
Cd40 is also a protein marker of EpiSC, and consistent with this,
we detected cell-surface expression of Cd40 in EPI at E5.5 (Fig-
ure 4B). Further examination of additional EpiSC protein markers
revealed Sirpa, Notch3, Cdh2, and Cd47 localized specifically to
EPI at E5.5 (Figure 4B). In contrast, ES cell proteins Pecam1,
Plxna4, and Pvrl3 were not detected in E5.5 embryos (data not
shown), confirming that the stage-specific fidelity of protein
markers that are able distinguish between ES cells and EpiSCproteins in individual samples of ES (blue), TS (red) and XEN (green) cells. Data
nts were recorded for each sample.
pression in a mixed sample containing equal numbers of ES, TS and XEN cells.
either Pecam1/Cdcp1/Pdgfra (upper right) or Cd81/Cd40/Dpp4 (lower right).
age-specific transcription factors. Pecam1 and Cd81-positive cells expressed
and Cd40-positive cells expressed high levels of TS-specific genes Cdx2 and
enes Gata6 and Sox17. Gene expression levels were normalized to the sample
1C for unstained control samples and details of gates used in flow cytometry
cells. Cell-surface markers of ES (Pecam1) and XEN (Dpp4 and Pdgfra) were
n addition to validation of XEN cell conversion using qRT-PCR, are shown in
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Figure 3. ES cells and EpiSC Can Be Identified and Isolated Using Cell-Surface Markers
(A) Venn diagram showing overlap of all cell-surface proteins detected in ES cells and EpiSC. See Table S2 for a list of proteins within each category.
(B) Immunofluorescent microscopy reveals the cellular localization and cell line specificity of candidate cell-surface proteins. Scale bar, 50 mm.
(C) Flow cytometry contour plots show that ES cells and EpiSC can be distinguished by the cell-surface markers Pecam1, Cd40, and Cd81. The same protein
markers allow monitoring of ES cell to EpiSC conversion. Confirmation of cell type by qRT-PCR analysis.
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our approach of using cell lines asmodels for identifying proteins
in cell-types that are not directly amenable to proteomic studies,
such as tissues in the early embryo. Sixteen proteins that we
identified using the stem cell lines were expressed by the ex-
pected embryo lineage, thus revealing previously unappreciated
expression patterns in the embryo and also providing potential
cell-surface markers for prospective cell isolation.
Prospective Isolation of Lineage-Specific Cells Directly
from Blastocysts by Flow Cytometry
We next examined whether it is possible to sort E4.5 blastocysts
into separate lineages using the protein/antibody combinations
identified (Figure 5A). To achieve this, there were several signif-
icant technical hurdles to overcome. We first determined condi-
tions that could dissociate blastocysts into single cells while
maintaining cell viability (see Experimental Procedures). Batches
of 30–50 embryos were processed per experiment and25% of
cells were recovered after single cell dissociation (5–15 cells
from each blastocyst). Cells were labeled with antibodies and
subjected to flow cytometry. Cell viability was 70% (based
on propidium iodide staining) and30% of cells were recovered
after flow cytometry. An unbiased computational analysis of the
flow cytometry data defined three distinct cell populations from
blastocysts, based upon the fluorescent intensity of each anti-
body (Figure 5B). We noticed that the proportion of TE cells
was reduced from75% in the blastocyst to15% of cells after
flow cytometry, with the remaining cells comprising equal
proportions of EPI and PE (Figure S3A). The reduction in TE
number was due to the difficulty in obtaining single viable cells,
however despite the lower numbers, sufficient TE cells were
obtained for analysis in each flow cytometry experiment. These
data indicate that each cell lineage had been successfully iso-
lated, thereby representing a significant advance in our ability
to analyze specific cell types within the early embryo.
To confirm the lineage identity of each cell population, we
sorted E4.5 blastocysts by flow cytometry and subjected indi-
vidual cells within each population to quantitative gene expres-
sion analysis using the BioMark Fluidigm System. Principle
component analysis revealed that Pecam1-positive (n = 25),
Pdgfra-positive (n = 23), and Cdcp1-positive (n = 15) cells
formed three distinct clusters and each cell type could be unam-
biguously identified based upon expression levels of known EPI,
PE, and TE genes (Figures 5C and 5D; Figure S3B). The clear
separation of lineage-specific transcription factor expression
suggests that each cell lineage is fully segregated in blastocysts
at E4.5. These data also provide an estimate of the error rate
during cell sorting. One EPI cell was falsely allocated into the
PE population, and one TE cell that was falsely sorted into the
EPI population, resulting in an error rate of 4%. An alternative(D) EpiSC to ES cell reprogramming was induced by forcing Nanog expression
Changes in cell fate were monitored by flow cytometry using the cell-surface mar
Cd47 negative) were detected on day nine (<0.5% of total population) and on da
(E) Each cell population was isolated by flow cytometry on day 13 and subjected
cells, but not to EpiSC.
(F) Isolated cell populations were transferred separately into media containing 2
markers characteristic of ES cells. Pecam1-positive/Cd47-negative cells displaye
their conversion to an ES cell phenotype. In addition, cells were isolated by flo
promoter was assayed by bisulphite sequencing.
Devecombination of antibodies, including Cd81 and Dpp4, showed
a similar trend in lineage-specific gene expression levels but
the cell populations were less distinct (Figure S3C).
Lastly, we assessed whether cells isolated from E4.5 blasto-
cysts by flow cytometry were viable, as this would enable sorted
cells to undergo functional assays. To test this, each sorted cell
population was transferred separately into ES, TS, and XEN cell
derivation conditions. Importantly, cells isolated from all three
lineages remained viable after 96 hr in culture. Differences in
stem cell derivation efficiency between each isolated population
also provide insight into the lineage restriction of each blastocyst
cell type. ES cell colonies emerged from the Pecam1 population
(EPI cells; efficiency of 19%) but no ES cell colonies developed
fromCdcp1 (TE cells) or Pdgfra (PE cells) populations (Figure 5E).
Conversely, numerous XEN cell colonies emerged from the
Pdgfra population (efficiency of 17%), but only one XEN cell
colony from Pecam1 cells (efficiency of 1.6%) and none from
Cdcp1 cells (Figure 5E). From Cdcp1-positive cells, we obtained
one TS cell colony (efficiency of 1%), whereas no TS cells
emerged from Pecam1 or Pdgfra-positive cells (Figure 5E). The
low derivation efficiency of TS colonies from Cdcp1-positive
cells is not unexpected, as even established TS cell lines have
lower clonal efficiency than ES and XEN cells (data not shown).
These data confirm that cells remain viable after embryo disso-
ciation and flow cytometry, thereby enabling functional studies
to be applied. Furthermore, each cell type only gave rise to the
appropriate stem cell lineage, indicating that EPI, PE, and TE
are lineage restricted in E4.5 embryos even when transferred
into conditions that are strongly selective for alternate stem
cell lineages.
DISCUSSION
We have developed a proteomic and bioinformatic strategy to
discover cell-surface proteins that are present on embryo-
derived stem cells, using an established cell-surface labeling
strategy (Borgia et al., 2010; Fac¸a et al., 2008; Schliemann
et al., 2010). We then screened a large panel of antibodies and
found 27 cell-surface proteins with lineage specificity. Each of
the four stem cell lines derived from the early mouse embryo
now has a defined cell-surface protein signature. We applied
this set of proteins/antibodies to several critical problems
currently encountered during in vitro differentiation and reprog-
ramming. Examination of ES cell to XEN cell differentiation,
and ES cell to EpiSC interconversion, confirmed the utility and
specificity of our protein markers and extended our under-
standing of these cellular processes. In regards to ES cells and
EpiSC, previous studies relied on transgene expression or the
judgment of cell morphology to detect reprogrammed cells
during EpiSC to ES cell conversion (Bao et al., 2009; Greberin EpiSC and transferring the cells into stringent ES cell conditions (2i/LIF).
kers Pecam1 and Cd47. Reprogrammed cells (defined as Pecam1 positive and
y 13 (1%–5% of total population depending on the experiment).
to qRT-PCR. Reprogrammed cells show similar gene expression profiles to ES
i/LIF (1,000 cells per well) and resultant colony outgrowths were assayed for
d alkaline phosphatase activity and Klf4 protein expression, thereby confirming
w cytometry on day 12 and the DNA methylation status of the Dppa3 (Stella)
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Figure 4. Immunofluorescent Confocal Microscopy of Candidate Cell-Surface Proteins in Mouse Embryos
(A) At E4.5, Pecam1, Cd81, Plxna4, and Pvrl3 expression was restricted to Nanog/Oct4-positive EPI cells; Cdcp1, Scarb1, and Ggt1 to Cdx2-positive TE cells;
and Pdgfra and Dpp4 to Gata6-positive cells. Robo2 and Cd40 was not detected at this developmental stage. Scale bar, 20 mm.
(B) At E5.5, Sirpa, Notch3, Cdh2, and Cd47were expressed in EPI; Cdcp1, Fgfr2, Cd40, andGgt1 in trophoblast; and Pdgfra and Robo2 to visceral endoderm and
parietal endoderm (arrows), respectively. Scale bar, 20 mm. Boxed sections indicate the enlarged regions (scale bar, 5 mm.). The visceral endodermwas removed
from some E5.5 embryos to improve antibody accessibility to EPI and trophoblast tissues.
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Figure 5. Prospective Isolation of Cell Lineages from Mouse Blastocysts by Flow Cytometry
(A) Immunofluorescent confocal section of Pecam1 (blue), Cdcp1 (red), and Pdgfra (green) in E4.5 blastocysts. Scale bar, 20 mm.
(B) Flow cytometry dot plot showing Pecam1, Cdcp1, and Pdgfra expression in cells isolated from E4.5 blastocysts. The combined data from three independent
experiments are shown. Computational analysis of the flow cytometry data defined three distinct cell populations, colored blue, green and red; gray dots
represent statistical outliers.
(C) Principle component (PC) projections of single cell gene expression profiles. Cells (n = 63) were isolated from E4.5 blastocysts using antibodies to Pecam1,
Pdgfra, and Cdcp1. The first PC is able to discriminate between EPI and TE/PE, the second PC between TE and PE/EPI.
(D) PC projections showing the contribution of each gene to the first two PCs. Fgf4, Klf2, Cripto, and Nanog are enriched in Pecam1-positive EPI, Gata4, Sox17,
FoxA2, and Gata6 are enriched in Pdgfra-positive PE, and Gata3, Cdx2, Eomes, and Fgfr2 are enriched in Cdcp1-positive TE. See Figure S3B for heat-maps of
expression data.
(E) E4.5 blastocysts were sorted by flow cytometry using a combination of Pecam1/Cdcp1/Pdgfra antibodies and each cell population was separately plated into
either ES, XEN, or TS cell derivation conditions. The resulting cell colonies were categorized as ES, TS, or XEN cells based upon expression of lineage markers.
Scale bar, 50 mm.
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Hall et al., 2009a; Hanna et al., 2010; Silva et al., 2009; Theunis-
sen et al., 2011; Zhang et al., 2010). Here, we present cell-
surface markers that can distinguish these two closely related
pluripotent cell types. It is likely that the identified protein
markers could also be used to study other reprogramming
events, such as the conversion of somatic cells to induced
pluripotent stem cells, which closely resemble ES cells
(Yamanaka, 2007).
Identifying mechanisms that regulate lineage restriction in the
embryo is essential for understanding cell fate decisions during
development and for improved control over stem cell differenti-
ation. Characterization of early embryo cells is also important
for providing a baseline to which cells can be compared after
reprogramming in order to better define their cellular phenotype
(Rossant, 2008). In keeping with these concepts, we show that
the majority of the cell line-specific proteins are expressed in
a lineage-appropriate manner in early mouse embryos. Our pro-
teomic resource also contains information on the differences in
expression of important cell-surface ligands and receptors that
can bemined to understand lineage development, differentiation
and reprogramming. In particular, interactions between cell-
surface proteins and extracellular ligands are key to regulating
cell behavior. Among the candidate proteins detected, the
expression of multiple Ephrin receptors in ES cells (Epha2/4,
Ephb2/3/4) and the Slit receptor Robo2 in the XEN cells is partic-
ularly intriguing, considering their known roles in guidance,
migration and control of stem cell proliferation (Brose and
Tessier-Lavigne, 2000; Genander and Frise´n, 2010). This could
suggest a potential role for Ephrin and Slit pathways during the
process of cell sorting that occurs during EPI and PE segregation
in the blastocyst (Plusa et al., 2008). In addition, identification of
CUB domain-containing protein 1 (Cdcp1) as a trophoblast-
specific cell-surface protein raises the possibility that Cdcp1
may be converting extracellular information into intracellular
signaling pathways, which is a key role for Cdcp1 in other epithe-
lial cell types (Wortmann et al., 2009). Thus, our proteomic
resource will provide a valuable set of protein targets for future
studies.
Gene expression profiles of EPI, TE, and PE have been
obtained by retrospective analyses of individual cells after blas-
tocyst disaggregation (Guo et al., 2010; Kurimoto et al., 2006).
These studies revealed that cells from each lineage in the blasto-
cyst could be distinguished according to their expression
profiles. Our demonstration of prospective sorting of EPI, TE,
and PE cells has several major advantages, including a priori
classification of cell types, grouping of cells for population
studies and the recovery of viable cells for functional character-
ization. This approach enabled us to quantify gene expression
levels of key transcription factors during lineage specification
and to perform functional in vitro assays to demonstrate that
cells expressing EPI, PE, or TE markers in blastocysts at E4.5
were lineage restricted. Our results are consistent with current
models of mouse development (Bruce and Zernicka-Goetz,
2010; Lanner and Rossant, 2010) and reveal that full segregation
of EPI, PE, and TE cells has occurred by E4.5. This methodology
enables direct access to the individual cell lineages of the early
embryo and isolation of viable lineage progenitors. Further
analysis of single cells by RNA sequencing and chimera forma-898 Developmental Cell 22, 887–901, April 17, 2012 ª2012 Elsevier Ition should accelerate investigation of early mammalian
development.
The proteomic strategy described here should be broadly
applicable to other developmental and stem cell systems, espe-
cially when combinedwith current large-scale efforts to generate
antibody libraries (Uhle´n et al., 2005). Future work to enhance our
proteomic resource could include alternative methodologies,
including affinity capture of glycosylated cell-surface proteins
(Wollscheid et al., 2009), to obtain a comprehensive overview
of cell-surface markers. In addition, cell-surface protein data
sets could be integrated with phosphoproteomic analysis of
intracellular proteins (Phanstiel et al., 2011) to generate a detailed
understanding of signaling pathways that regulate self-renewal
and differentiation.
EXPERIMENTAL PROCEDURES
Cell Lines
ES cell lines R1 (129X1 3 129S1; passages 12–16) (Nagy et al., 1993) and
E14TG2a (129P2/OlaHsd; passages 18–22) (Hooper et al., 1987), TS cell lines
F4 (Institute for Cancer Research [ICR]; passages 12–16) and Rosa (ICR
[Gt(ROSA)26Sor / +]; passages 8–12), and XEN cell lines A4 (ICR; passages
10–14) and E4 (ICR; passages 12–15) were derived from E3.5 blastocysts
and cultured in the absence of feeder-cells as previously described (Rugg-
Gunn et al., 2010). EpiSC lines 129S2 (passages 14–20) and B2 (ICR; passages
8–16) were derived as described (Brons et al., 2007). EpiSC were cultured in
N2B27 media (Ying and Smith, 2003) supplemented with 10 ng/ml Activin A
and 12 ng/ml bFGF on fibronectin or irradiated mouse embryonic fibroblasts.
Sox17-inducible ES cells were generated by electroporation of R1 ES cells
with 5 mg of PB-TET-Sox17, 5 mg pCAG-rtTA-Puro, and 100 ng pCAG-PBase
(Wang et al., 2008b) followed by puromycin selection (1.25 mg/ml). To induce
extraembryonic endoderm differentiation, Sox17-ES cells were treated for
12 days with 100 ng/ml doxycycline (Sigma) in ES cell media.
ES cell to EpiSC conversion was accomplished by transferring 50,000 ES
cells into one well of a 6-well plate, precoated with fibronectin, in EpiSCmedia.
Media was changed daily and cells passaged after four days. EpiSC to ES cell
reprogramming was performed by transferring 500,000 Nanog-EpiSC into one
well of a six-well plate, precoated with irradiatedmouse embryonic fibroblasts,
in ES cell media supplemented with 1 mM PD0325901, 3 mM CHIR99021,
1000 U/ml LIF, and 1,000 ng/ml doxycycline (Sigma). Nanog-overexpressing
EpiSCs (129S2 line) were generated using Lipofectamine 2000 (Invitrogen)
and 1 mg of PB-TET-Nanog-ires-GFP, 1 mg pCAG-rtTA-Puro, and 2 mg
pCAG-PBase (Wang et al., 2008b) followed by puromycin selection (1.2 mg/ml).
Mouse Embryos
Embryos were collected at appropriate time points from timed natural matings
of ICR outbred mice. Preimplantation embryos were flushed from uteri at E3.5
with M2 media (Millipore). E4.5 embryos were obtained by culturing E3.5
embryos for 24 hr in KSOM supplemented with amino acids (Millipore) at
37C in 5%CO2. E5.5 embryoswere dissected fromdecidua in PBS. All animal
work was carried out following Canadian Council on Animal Care Guidelines
for Use of Animals in Research and Laboratory Animal Care under protocols
approved by the Toronto Centre for Phenogenomics Animal Care Committee.
Sample Preparation, MudPIT Analyses, and Protein Identification
In situ biotinylation of ES, TS, XEN, and EpiSC was carried out as previously
described (Roesli et al., 2006). Sample preparation, digestion, MudPIT anal-
yses and protein identifications were as previously described (Elschenbroich
et al., 2009; Taylor et al., 2009). Experimental procedures are detailed in
Supplemental Experimental Procedures.
Flow Cytometry of Cell Lines and Blastocysts
Single-cell suspensions of ES, TS, XEN, and EpiSC were obtained by dissoci-
ating with 0.05% trypsin or cell dissociation buffer (Invitrogen) at 37C. Blasto-
cysts (typically 30–50 per experiment) were treated with acid Tyrode’s solutionnc.
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20 min at 37C, followed by Hanks’-based cell dissociation buffer (Invitrogen)
for 20 min on ice, then manually dissociated into single cells using a finely
pulled glass capillary. Cells were incubated with primary antibody (Supple-
mental Experimental Procedures) in staining buffer (2% FBS in PBS) for
30 min on ice. Cells were washed once with staining buffer, incubated with
secondary antibody in staining buffer for 30 min on ice and washed once in
staining buffer. Cells were suspended in 0.2 mg/ml propidium iodide in staining
buffer.
For ES, TS, and XEN cell derivation, embryo cells were sorted into ES cell
media (Lanner et al., 2010) supplemented with 1 mM PD0325901, 3 mM
CHIR99021, and 1000 U/ml LIF (Ying et al., 2008) or TS/XEN cell media
(Rugg-Gunn et al., 2010) supplemented with 30 ng/ml FGF4 and 1 mg/ml
heparin.
Flow cytometry was performed at the Sickkids - UHN Flow Cytometry
Facility using a Becton Dickinson LSR II and Dako Cytomation MoFlo. At least
10,000 final events were recorded for each flow cytometry analysis.
Gene Expression Analysis
Single cell gene expression analysis was performed using 48.48 Dynamic
Arrays on the BioMark System (Fluidigm). Individual cells were flow sorted
directly into 5 ml RT-PreAmp Master Mix, containing CellsDirect 23 Reaction
Mix (Invitrogen), 0.23 assay pool of recommended TaqMan GeneExpression
Assays (203, Applied Biosystems), and RT/Taq Enzyme (CellsDirect qRT-
PCR kit, Invitrogen). Cell lysis, sequence-specific reverse transcription
(50C for 20 min) and sequence-specific amplification (18 cycles of: 95C
for 15 s, 60C for 4 min) were performed immediately following flow sorting.
The preamplified product was diluted 5-fold before being analyzed on 48.48
Dynamic Arrays on the BioMark System with TaqMan GeneExpression
Assays (Applied Biosystems). Ct values were calculated using Biomark’s
Real-time PCR Analysis software. Each reaction for each plate was filtered
by using the pass fail quality control metric (Fluidigm) and normalized
against Actb. Cells with low (Actb Ct value > 16) or absent amplification
were excluded from the analysis. Reactions that failed due to quality or no
product were set to the maximum observed Ct value plus 1. Data were
rescaled by subtracting the observed Ct value from the maximum plus 1,
which results in a positive scale of increasing value proportional to
increasing transcript. Data were analyzed in R. Heat maps were made using
the heatmap.2 function from the gplots package, principal component anal-
ysis was calculated using the prcomp function and plotted with the plot
function.
RNA was extracted from bulk flow-sorted cells using Trizol (Invitrogen) and
the RNeasy Micro kit (QIAGEN). RNA (1 mg for cell lines, or entire sample for
blastocyst cells) was reverse transcribed using the QuantiTect Reverse
Transcription Kit (QIAGEN) and subjected to quantitative PCR analysis as
previously described (Rugg-Gunn et al., 2010).
Statistical Analysis
We used t tests to calculate p values for the fold change difference between
the membrane and nonmembrane fractions, based on spectral counts in the
replicates for each fraction. p values were corrected for multiple testing using
the Benjamini and Hochberg false discovery rate. Enrichment for gene
ontology terms was examined using Database for Annotation, Visualization
and Integrated Discovery (DAVID) v6.7 software (Dennis et al., 2003). Enrich-
ment value and Fisher’s exact p value are indicated in the text. flowClust
provides methods for identification of statistically distinct cell populations
through modeling of cytometric data (Lo et al., 2009). Optimal models are
determined using the Bayesian Information Criterion.
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